WOOJUNG BIO Inc (KQ:215380) — Market Cap & Net Worth
Market Cap & Net Worth: WOOJUNG BIO Inc (215380)
WOOJUNG BIO Inc (KQ:215380) has a market capitalization of $32.48 Million (₩47.93 Billion) as of May 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23456 globally and #1671 in its home market, demonstrating a -8.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying WOOJUNG BIO Inc's stock price ₩2875.00 by its total outstanding shares 16670536 (16.67 Million). Analyse WOOJUNG BIO Inc cash flow conversion to see how efficiently the company converts income to cash.
WOOJUNG BIO Inc Market Cap History: 2015 to 2026
WOOJUNG BIO Inc's market capitalization history from 2015 to 2026. Data shows change from $56.49 Million to $32.48 Million (-5.61% CAGR).
Index Memberships
WOOJUNG BIO Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$306.89 Billion | 0.01% | #872 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$306.89 Billion | 0.01% | #872 of 1384 |
Weight: WOOJUNG BIO Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
WOOJUNG BIO Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how WOOJUNG BIO Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
WOOJUNG BIO Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.09x
WOOJUNG BIO Inc's market cap is 0.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $56.35 Million | $21.48 Billion | $77.25 Million | 0.00x | 0.73x |
| 2017 | $64.25 Million | $28.93 Billion | -$6.92 Billion | 0.00x | N/A |
| 2018 | $58.46 Million | $23.76 Billion | -$3.98 Billion | 0.00x | N/A |
| 2019 | $60.67 Million | $32.29 Billion | $279.59 Million | 0.00x | 0.22x |
| 2020 | $106.53 Million | $37.34 Billion | -$10.88 Billion | 0.00x | N/A |
| 2021 | $71.06 Million | $31.24 Billion | -$1.93 Billion | 0.00x | N/A |
| 2022 | $33.72 Million | $46.92 Billion | -$1.88 Billion | 0.00x | N/A |
| 2023 | $23.61 Million | $38.62 Billion | -$5.05 Billion | 0.00x | N/A |
| 2024 | $19.21 Million | $43.20 Billion | $225.30 Million | 0.00x | 0.09x |
Competitor Companies of 215380 by Market Capitalization
Companies near WOOJUNG BIO Inc in the global market cap rankings as of May 5, 2026.
Key companies related to WOOJUNG BIO Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $109.06 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #357 globally with a market cap of $73.69 Billion USD.
- UCB SA (BR:UCB): Ranked #519 globally with a market cap of $50.85 Billion USD ( €43.50 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #567 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $109.06 Billion | $429.85 |
| #357 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.69 Billion | $709.21 |
| #519 | UCB SA | BR:UCB | $50.85 Billion | €228.50 |
| #567 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
WOOJUNG BIO Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, WOOJUNG BIO Inc's market cap moved from $56.49 Million to $ 32.48 Million, with a yearly change of -5.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩32.48 Million | +63.26% |
| 2025 | ₩19.89 Million | +3.59% |
| 2024 | ₩19.21 Million | -18.66% |
| 2023 | ₩23.61 Million | -29.98% |
| 2022 | ₩33.72 Million | -52.54% |
| 2021 | ₩71.06 Million | -33.30% |
| 2020 | ₩106.53 Million | +75.61% |
| 2019 | ₩60.67 Million | +3.77% |
| 2018 | ₩58.46 Million | -9.01% |
| 2017 | ₩64.25 Million | +14.04% |
| 2016 | ₩56.35 Million | -0.25% |
| 2015 | ₩56.49 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of WOOJUNG BIO Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.48 Million USD |
| MoneyControl | $32.48 Million USD |
| MarketWatch | $32.48 Million USD |
| marketcap.company | $32.48 Million USD |
| Reuters | $32.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About WOOJUNG BIO Inc
WOOJUNG BIO, Inc. provides non-clinical research agency services. The company was founded in 1989 and is based in Hwaseong-si, South Korea.